MOORESTOWN, N.J., Dec. 20, 2017 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) previously announced that its subsidiary, SinfoníaRx, Inc., has partnered with The Health Plan of San Mateo (HPSM), a non-profit county organized health system that offers medical and support services for Medi-Cal eligible residents in San Mateo County, California. TRHC, a healthcare technology company, is a leading provider of Medication Therapy Management (MTM) solutions.
“We welcome the opportunity to collaborate with HPSM to support and help optimize the medication management needs of its members,” said Calvin H. Knowlton, PhD, CEO, TRHC.
The average Medicare beneficiary takes more than 10 medications a day which increases the likelihood of an adverse drug event (ADE). In order to improve health outcomes, the Centers for Medicare and Medicaid Services (CMS) mandate that Medicare Part D MTM programs work to reduce ADEs. TRHC offers a wide range of MTM programs to meet CMS requirements, improve STAR ratings and meet goals for improved health and wellness and overall patient care.
“Our partnership with The Health Plan of San Mateo presents another opportunity to expand the reach of SinfoníaRx’s innovative suite of medication management services,” says Kevin Boesen, PharmD, Chief Executive Officer of SinfoníaRx. “Moreover, our collaboration with HPSM will lead to further expansion of the Tabula Rasa HealthCare network of patient-centric support and solutions.” Tabula Rasa HealthCare is a leader in medication risk mitigation.
TRHC provides best-in-class MTM services to patients and providers across the nation. More than half of all Americans take an average of four prescription medications a day which increases the likelihood of an adverse drug event (ADE). MTM programs are designed to enhance a personalized approach to medication management with the goal of optimizing the effectiveness and safety of medication regimens.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payors, providers and other healthcare organizations.
SinfoníaRx, a subsidiary of Tabula Rasa HealthCare, is a rapidly growing healthcare technology company offering innovative solutions for health entities (health plans, health systems, provider organizations, and pharmacy organizations), patients and caregivers.
For more information, please visit: www.TRHC.com.
Media Contact
Dianne Semingson
[email protected]
T: 215-870-0829
Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



